Vanderbilt-Ingram Cancer Center is now participating in CancerLinQ, a technology initiative focused on improving patient care that tracks quality metrics in real time.

Jordan Berlin, MD, has been named director of Vanderbilt’s Division of Hematology and Oncology.

Vanderbilt surgeons recently treated a pancreatic cancer patient using IntraOp Mobetron IORT with electrons — the first surgery performed in Tennessee with this new technology utilizing intraoperative radiotherapy in the operating room.

Autoantibodies against the p53 tumor suppressor protein may be a novel biomarker for identifying people, especially African Americans, at high risk for lung cancer.

A new approach for conducting gene-based analyses for cancer susceptibility created at Vanderbilt outperforms existing models.

Vanderbilt's Christine Lovly, MD, PhD, has received the 2022 Asclepios Award, which recognizes lung cancer research pioneers.

The program features speakers from different hospital departments, staff testimonials of patients at the end of their lives, a reading of loved ones’ names and special music.